Anuncio
Anuncio

DNLI

DNLI logo

Denali Therapeutics Inc. Common Stock

23.49
USD
Patrocinado
+1.56
+7.11%
17 jun, 16:00 UTC -4
Cerrado
exchange

Post-mercado

23.65

+0.16
+0.67%

Panorámica financiera de Denali Therapeutics Inc. Common Stock

Cap. de Mercado
3.75B
Beta
1.10
Beneficios Por Acción (BPA)
-2.97
Ratio Precio/Valor (P/V) Contable
2.79
Margen de explotación
--
Ratio de Endeudamiento total (D/C)
0.55%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
-50.13%
Ratio de liquidez
9.16%
Flujo de caja libre
-422.10M
Perfil de DNLI

Gráfico de Beneficios

Beneficios de DNLI

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$1043.19
+2.20%
Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$191.82
-4.95%
Nvidia Corp logo
Nvidia Corp$204.65
-1.33%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1958.80
-1.64%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$396.38
-2.05%
Microsoft Corp logo
Microsoft Corp$378.91
-3.79%
Broadcom Inc. Common Stock logo
Broadcom Inc. Common Stock$392.90
+4.30%
Anuncio